GYRE EBITDA | Gyre Therapeutics, Inc.

Gyre Therapeutics, Inc. (GYRE) EBITDA

2026-06-30: Basis Reported; EBITDA -$12.88M*; Operating income -$14.36M; Depreciation and amortization $1.48M*.
2026-03-31: Basis Reported; EBITDA -$8.68M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $774,000.00; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $7.21M*; Operating income $6.92M; Depreciation and amortization $281.00K*.

Complete source-backed ebitda history.

Available history: 2009-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	-$12.88M*	-$14.36M	$1.48M*	$29.11M	-44.25%*	$262.00K*	-$16.73M*	$2.21M	(m)	$7.86M	-$164.00K
2026-03-31	Reported	-$8.68M	(m)	(m)	(m)	-38.56%	$178.00K	$3.18M	$1.23M	$6.74M	(m)	$621.00K
2025-12-31	Reported	$774,000.00	(m)	(m)	(m)	2.08%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$7.21M*	$6.92M	$281.00K*	$30.56M	23.58%*	$589.00K*	$14.24M*	$1.63M	$2.36M	(m)	$1.69M
2025-06-30	Reported	-$1.23M*	-$2.24M	$1.01M*	$29.73M	-4.14%*	$335.00K*	-$7.47M*	$1.15M	$8.35M	$7.28M	$662.00K
2025-03-31	Reported	$2.81M	(m)	(m)	(m)	12.73%	$122.00K	-$129.00K	$894.00K	$3.10M	(m)	$901.00K
2024-12-31	Reported	$1.13M	(m)	(m)	(m)	4.04%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$4.68M*	$4.23M	$445.00K*	$25.49M	18.35%*	$693.00K*	$1.73M*	$958.00K	$2.77M	(m)	$1.07M
2024-06-30	Reported	$3.42M*	$3.19M	$228.00K*	$25.23M	13.57%*	$1.46M*	-$5.49M*	$770.00K	$3.35M	(m)	$1.50M
2024-03-31	Reported	$8.49M	(m)	(m)	(m)	31.23%	$231.00K	$2.88M	$979.00K	$2.18M	(m)	$2.55M
2023-12-31	Reported	-$91.33M	(m)	(m)	(m)	-336.43%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	$12.96M*	$12.76M	$192.00K*	$32.04M	40.43%*	$1.97M*	$7.58M*	$1.18M	$3.01M	(m)	$3.68M
2023-06-30	Reported	$5.28M*	$4.97M	$308.00K*	$29.33M	18.01%*	$2.48M*	$4.53M*	$1.08M	$3.57M	(m)	$2.08M
2023-03-31	Reported	$6.94M	(m)	(m)	(m)	27.84%	$1.74M	$10.42M	$1.13M	$2.63M	(m)	$2.05M
2022-12-31	Reported	-$21.59M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$5.13M*	-$5.17M	$40.00K*	(m)	(m)	(m)	-$7.28M*	(m)	$803.00K	(m)	$0.00
2022-06-30	Reported	$51.60M*	$51.53M	$67.00K*	(m)	(m)	(m)	-$12.29M*	(m)	$1.87M	(m)	$0.00
2022-03-31	Reported	-$14.59M	(m)	(m)	(m)	-1837.28%	(m)	-$12.05M	(m)	$9.70M	(m)	$0.00
2021-12-31	Reported	-$20.2M	(m)	(m)	(m)	-827.79%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$25.14M*	-$25.23M	$85.00K*	$2.30M	-1093.69%*	$492.00K*	-$21.60M*	(m)	$20.35M	(m)	(m)
2021-06-30	Reported	-$19.87M*	-$19.91M	$45.00K*	$1.13M	-1755.21%*	(m)	-$20.12M*	(m)	$15.39M	(m)	(m)
2021-03-31	Reported	-$22.39M	(m)	(m)	(m)	-1526.45%	(m)	-$24.36M	(m)	$17.01M	(m)	(m)
2020-12-31	Reported	-$18.8M	(m)	(m)	(m)	-925.46%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	-$16.06M*	-$16.10M	$42.00K*	$893.00K	-1798.21%*	$195.00K*	-$13.01M*	(m)	$12.25M	(m)	(m)
2020-06-30	Reported	-$17.34M*	-$17.36M	$26.00K*	$1.66M	-1045.54%*	$16.00K*	-$15.14M*	(m)	$12.91M	(m)	(m)
2020-03-31	Reported	-$5.04M	(m)	(m)	(m)	-30.81%	$17.00K	-$4.79M	(m)	$13.26M	(m)	(m)
2019-12-31	Reported	-$13.95M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$13.16M*	-$13.20M	$33.00K*	(m)	(m)	$1.00K*	-$9.10M*	(m)	$9.93M	(m)	(m)
2019-06-30	Reported	-$14.35M*	-$14.38M	$34.00K*	(m)	(m)	$49.00K*	-$11.47M*	(m)	$11.11M	(m)	(m)
2019-03-31	Reported	-$15.67M	(m)	(m)	(m)	(m)	$15.00K	-$14.96M	(m)	$12.03M	(m)	(m)
2018-12-31	Reported	-$11.64M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$8.31M*	-$8.35M	$36.00K*	$0.00*	(m)	$0.00*	-$7.02M*	(m)	$5.58M	(m)	(m)
2018-06-30	Reported	-$7.08M*	-$7.11M	$37.00K*	$0.00*	(m)	$3.00K*	-$7.41M*	(m)	$3.89M	(m)	(m)
2018-03-31	Reported	-$6.65M	(m)	(m)	(m)	-110766.67%	$198.00K	-$5.11M	(m)	$3.77M	(m)	(m)
2017-12-31	Reported	-$5.79M	(m)	(m)	(m)	-1820.13%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$5.84M*	-$5.88M	$41.00K*	$318.00K	-1835.53%*	$0.00*	-$4.93M*	(m)	$3.81M	(m)	(m)
2017-06-30	Reported	-$5.90M*	-$5.94M	$43.00K*	$111.00K	-5316.22%*	$0.00*	(m)	(m)	$3.40M	(m)	(m)
2017-03-31	Reported	-$4.12M	(m)	(m)	(m)	(m)	$3.00K	(m)	(m)	$2.06M	(m)	(m)
2016-12-31	Reported	-$5.16M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$5.60M*	-$5.71M	$108.00K*	(m)	(m)	$22.00K*	(m)	(m)	$3.40M	(m)	(m)
2016-06-30	Reported	-$4.80M*	-$4.92M	$115.00K*	(m)	(m)	$235.00K*	(m)	(m)	$2.75M	(m)	(m)
2016-03-31	Reported	-$4.47M	(m)	(m)	(m)	(m)	$89.00K	(m)	(m)	$2.29M	(m)	(m)
2015-12-31	Reported	-$4.58M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$3.78M*	-$3.88M	$107.00K*	(m)	(m)	(m)	(m)	(m)	$1.49M	(m)	(m)
2015-06-30	Reported	-$2.06M*	-$2.20M	$145.00K*	(m)	(m)	(m)	(m)	(m)	$1.32M	(m)	$0.00*
2015-03-31	Reported	-$2.92M	(m)	(m)	(m)	-4865.00%	(m)	(m)	(m)	$1.38M	(m)	$21.00K
2014-12-31	Reported	-$1.72M	(m)	(m)	(m)	-1354.33%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$1.48M*	-$1.64M	$162.00K*	(m)	(m)	(m)	(m)	(m)	$1.34M	(m)	$11.00K
2014-06-30	Reported	-$1.84M*	-$2.21M	$370.00K*	(m)	(m)	(m)	-$8.91M*	(m)	$5.41M	(m)	$45.00K
2014-06-30	Reported	(m)	-$2.21M	(m)	(m)	(m)	(m)	(m)	(m)	$1.29M	(m)	(m)
2014-03-31	Reported	-$11.69M	(m)	(m)	(m)	-13433.33%	(m)	-$14.85M	(m)	$9.08M	(m)	$3.41M
2013-12-31	Reported	$24.24M	(m)	(m)	(m)	26064.52%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$13.01M*	-$13.15M	$139.00K*	(m)	(m)	$0.00*	-$9.71M*	(m)	$10.31M	(m)	(m)
2013-06-30	Reported	-$12.32M*	-$12.49M	$170.00K*	(m)	(m)	$22.00K*	-$10.41M*	(m)	$9.45M	(m)	(m)
2013-03-31	Reported	-$8.06M	(m)	(m)	(m)	-227.97%	$70.00K	-$9.32M	(m)	$8.32M	(m)	(m)
2012-12-31	Reported	-$15.86M	(m)	(m)	(m)	-2688.14%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$7.55M*	-$8.10M	$550.00K*	(m)	(m)	$1.00K*	-$10.40M*	(m)	$6.43M	(m)	$0.00
2012-06-30	Reported	$14.86M*	$14.23M	$630.00K*	(m)	(m)	$91.00K*	-$17.34M*	(m)	$12.51M	(m)	$0.00
2012-03-31	Reported	$2.62M	(m)	(m)	(m)	11.45%	$46.00K	-$24.90M	(m)	$17.80M	(m)	(m)
2011-12-31	Reported	-$9.52M	(m)	(m)	(m)	-50.25%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	-$8.71M*	-$9.33M	$619.00K*	(m)	(m)	$167.00K*	-$18.08M*	(m)	$25.44M	(m)	$0.00
2011-06-30	Reported	-$1.94M*	-$2.57M	$635.00K*	(m)	(m)	$414.00K*	-$23.06M*	(m)	$20.18M	(m)	$0.00
2011-03-31	Reported	$12.9M	(m)	(m)	(m)	33.09%	$598.00K	-$22.05M	(m)	$23.52M	(m)	(m)
2010-12-31	Reported	-$819,000.00	(m)	(m)	(m)	-3.49%	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	$2.95M*	$2.42M	$531.00K*	(m)	(m)	$197.00K*	-$16.99M*	(m)	$17.33M	(m)	$257.00K
2010-06-30	Reported	(m)	$4.97M	(m)	(m)	(m)	(m)	(m)	(m)	$14.12M	(m)	$1.51M

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$13.97M	(m)	(m)	(m)	11.98%	$1.19M	$1.01M	$5.42M	$13.70M	(m)	$4.56M
2024-12-31	Reported	$17.71M	(m)	(m)	(m)	16.75%	$2.31M	-$3.64M	$3.88M	$12.02M	(m)	$5.32M
2023-12-31	Reported	-$66.16M	(m)	(m)	(m)	-58.31%	$8.52M	$25.89M	$4.64M	$13.78M	(m)	$8.52M
2022-12-31	Reported	$10.29M	(m)	(m)	(m)	10.06%	$4.99M	$10.68M	$4.79M	(m)	(m)	$5.10M
2021-12-31	Reported	-$87.6M	(m)	(m)	(m)	-1193.84%	$839.00K	-$83.75M	(m)	$68.89M	(m)	(m)
2020-12-31	Reported	-$57.23M	(m)	(m)	(m)	-273.21%	(m)	-$55.05M	(m)	$52.98M	(m)	(m)
2019-12-31	Reported	-$57.13M	(m)	(m)	(m)	(m)	$64.00K	-$43.61M	(m)	$43.86M	(m)	(m)
2018-12-31	Reported	-$33.67M	(m)	(m)	(m)	-561216.67%	$376.00K	-$28.55M	(m)	$21.47M	(m)	(m)
2017-12-31	Reported	-$21.65M	(m)	(m)	(m)	-2126.62%	$23.00K	-$19.94M	(m)	$12.85M	(m)	(m)
2016-12-31	Reported	-$20.03M	(m)	(m)	(m)	(m)	$468.00K	(m)	(m)	$11.55M	(m)	(m)
2016-09-30	Rolling	(m)	-$19.88M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Rolling	(m)	-$18.05M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Rolling	(m)	-$15.34M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	-$13.33M	(m)	(m)	(m)	(m)	$272.00K	(m)	(m)	$5.96M	(m)	(m)
2015-12-31	Rolling	(m)	-$13.80M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Rolling	(m)	-$10.92M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-30	Rolling	(m)	-$8.67M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	-$6.83M	(m)	(m)	(m)	-2483.27%	$4.00K	(m)	(m)	$5.27M	(m)	$3.48M
2014-03-31	Rolling	(m)	-$40.80M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-31	Reported	-$9.15M	(m)	(m)	(m)	-252.03%	$41.00K	-$40.61M	(m)	$6.56M	(m)	$7.00K
2013-12-31	Rolling	(m)	-$47.22M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Rolling	(m)	-$50.17M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-06-30	Rolling	(m)	-$45.12M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-03-31	Rolling	(m)	-$18.40M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-12-31	Reported	-$5.93M	(m)	(m)	(m)	-10.24%	$333.00K	-$64.24M	(m)	$49.09M	(m)	-$101.00K
2012-12-31	Rolling	(m)	-$8.14M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Rolling	(m)	-$2.02M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-06-30	Rolling	(m)	-$3.26M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-03-31	Rolling	(m)	-$20.06M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-12-31	Reported	-$7.27M	(m)	(m)	(m)	-7.44%	$1.43M	-$83.72M	(m)	$95.22M	(m)	$0.00
2011-12-31	Rolling	(m)	-$9.74M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-12-31	Reported	$15.11M	(m)	(m)	(m)	17.63%	$3.31M	$138.30M	(m)	$64.55M	(m)	$3.53M
2009-12-31	Reported	-$38.49M	(m)	(m)	(m)	-153.58%	$200.00K	-$24.27M	(m)	$40.18M	(m)	-$88.00K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
LEXICON PHARMACEUTICALS, INC. (LXRX)	United States	$0.823B	-17.48
Obsidian Therapeutics, Inc. (OBX)	United States	$0.829B
GERON CORP (GERN)	United States	$0.803B	-12.14
Immix Biopharma, Inc. (IMMX)	United States	$0.837B	-18.44
Avalo Therapeutics, Inc. (AVTX)	United States	$0.842B	-9.74
Aclaris Therapeutics, Inc. (ACRS)	United States	$0.792B	-9.78
Olema Pharmaceuticals, Inc. (OLMA)	United States	$0.790B	-5.35
Wave Life Sciences, Inc. (WVE)		$0.780B	-5.56
ARDELYX, INC. (ARDX)	United States	$0.857B	-22.86
Design Therapeutics, Inc. (DSGN)	United States	$0.766B	-12.78